Endo gets fentanyl patch rights from Noven
Transdermal drug delivery company Noven Pharmaceuticals licensed Endo Pharmaceuticals (pain management) US and Canadian rights to its transdermal fentanyl patch, currently in development to treat chronic pain.
- Specialty Pharmaceuticals
- Includes Contract
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com